欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/2356/002
药品名称Meriofert Set
活性成分
    • menotropin 150.0 IU
剂型Powder and solvent for solution for injection
上市许可持有人IBSA Farmaceutici Italia S.r.l Via Martiri di Cefalonia 2 26900 Lodi Italien
参考成员国 - 产品名称Denmark (DK)
Meriofert/Meriofert Set
互认成员国 - 产品名称
    • Luxembourg (LU)
      Mensinorm 150 UI Poudre et solvant pour solution injectable
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Meriofert PFS 150 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
      MERIOFERT (ex MENOTROPHIN/LABORATOIRES GENEVRIER)
    • Poland (PL)
    • Bulgaria (BG)
      Meriofert PFS
    • Cyprus (CY)
      MENOTROPHIN LG PWD AND SOLVENT FOR SOL FOR INJ
    • Czechia (CZ)
      Menotrophin LG (150 IU)
    • Romania (RO)
      MERIOFERT PFS 150 UI pulbere şi solvent pentru soluţie injectabilă
    • Slovakia (SK)
    • Norway (NO)
    • Estonia (EE)
      Meriofert Set
    • Finland (FI)
    • Latvia (LV)
      Meriofert Set 150 SV pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
    • Sweden (SE)
    • Lithuania (LT)
    • Belgium (BE)
      MENSINORM 150 IU Poudre et solvant pour solution injectable
    • Netherlands (NL)
许可日期2014/12/18
最近更新日期2024/10/08
药物ATC编码
    • G03GA02 human menopausal gonadotrophin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Other
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase